Molecular genetic studies of schizophrenia

European Journal of Human Genetics

Volumn 14, Issue 6, 2006, Pages 669-680

  Riley, Brien ^a   Kendler, Kenneth S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Association; Genes; Genetic epidemiology; Linkage; Molecular genetics; Schizophrenia

Indexed keywords

BINDING PROTEIN; CALCINEURIN; CATECHOL METHYLTRANSFERASE; DEXTRO AMINO ACID OXIDASE; DNA; DYSTROBREVIN BINDING PROTEIN 1; NEU DIFFERENTIATION FACTOR; PROLINE DEHYDROGENASE; PROTEIN KINASE B; PROTEIN SUBUNIT; RECEPTOR PROTEIN; RGS PROTEIN; UNCLASSIFIED DRUG;

BEHAVIOR GENETICS; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 8P; EVIDENCE BASED MEDICINE; FAMILY STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENETIC SCREENING; GENETIC TRAIT; GENETIC VARIABILITY; HEREDITY; HUMAN; HUMAN GENOME; LINKAGE ANALYSIS; MENTAL DISEASE; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PRIORITY JOURNAL; RELATIVE; REVIEW; SCHIZOPHRENIA; TWINS;

GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE; SCHIZOPHRENIA;

EID: 33744458952     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201571     Document Type: Review

References (89)

1. Gottesman II: Schizophrenia Genesis. New York: W H Freeman, 1991.
2. Kendler KS, Diehl SR: TheAgenetics of schizophrenia: a current, genetic-epidemiologic perspective. Schizophr Bull 1993; 19: 261-285.
3. Cardno AG, Gottesman II: Fwin studies of schizophrenia: from bow-and-arrow concordances to Star Wars Mx and functional genomics. Am J Med Genet 2000; 97: 12-17.
4. Tienari P, Wynne LC, Sorri A et al: Genotype-environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees. Br J Psychiatry 2004; 184: 216-222.
5. Prescott CA, Gottesman II: Genetically mediated vulnerability to schizophrenia. Psychiatr Clin N Am 1993; 16: 245-267.
6. Tienari P: Interaction between genetic vulnerability and family environment: The Finnish adoptive family study of schizophrenia. Acta Psychiatr Scand 1991; 84: 460-465.
7. Kety SS, Wender PH, Jacobsen B et al: Mental illness in the biological and adoptive relatives of schizophrenic adoptees: Replication of the Copenhagen study in the rest of Denmark. Arch Gen Psychiatry 1994; 51: 442-455.
8. McGue M, Gottesman I, Rao DC: Resolving genetic models for the transmission of schizophrenia. Genet Epidemiol 1985; 2: 99-110.
9. Kendler KS, McGuire M, Gruenberg AM, Spellman M, O'Hare A, Walsh D: The Roscommon family study: II. The risk of nonschizophrenic nonaffective psychoses in relatives. Arch Gen Psychiatry 1993; 50: 645-652.
10. Riley B, Kendler KS: Lenetics of schizophrenia: linkage and association studies; in Kendler KS, Eaves LJ (eds): Psychiatric Genetics. Washington DC: American Psychiatric Publishing Incorporated, 2005, pp 95-140.
11. Pulver AE, Karayiorgou M, Wolyniec PS et al: Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 1994; 54: 36-43.
12. Gill M, Vallada H, Collier D et al: A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12. Am J Med Genet Neuropsychiatr Genet 1996; 67: 40-45.
13. Murphy KC, Jones LA, Owen MJ: High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945.
14. Egan MF, Goldberg TE, Kolachana BS et al: Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
15. Shifman S, Bronstein M, Sternfeld M et al: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296-1302.
16. Glatt SJ, Faraone SV, Tsuang MT: Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003; 160: 469-476.
17. Fan JB, Zhang CS, Gu NF et al: Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis. Biol Psychiatry 2005; 57: 139-144.
18. Williams HJ, Glaser B, Williams NM et al: No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 2005; 162: 1736-1738.
19. Liu H, Heath SC, Sobin C et al: Genetic variation at the 22q11 PRODH2/ DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA 2002; 99: 3717-3722.
20. Fan JB, Ma J, Zhang CS et al: A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population. Neurosci Lett 2003; 338: 252-254.
21. Mukai J, Liu H, Burt RA et al: Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat Genet 2004; 36: 725-731.
22. Chen WY, Shi YY, Zheng YL et al: Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum Mol Genet 2004; 13: 2991-2995.
23. Pulver AEA Lasseter VK, Kasch L et al: Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet Neuropsychiatr Genet 1995; 60: 252-260.
24. Levinson DF, Wildenauer DB, Schwab SG et al: Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study. Am J Med Genet Neuropsychiatr Genet 1996; 67: 580-594.
25. Stefansson H, Sigurdsson E, Steinthorsdottir V et al: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892.
26. Stefansson H, Sarginson J, Kong A et al: Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83-87.
27. Corvin AP, Morris DW, McGhee K et al: Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry 2004; 9: 208-213.
28. Williams NM, Preece A, Spurlock G et al: Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003; 8: 485-487.
29. Thiselton DL, Webb BT, Neale BM et al: No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry 2004; 9: 777-783.
30. Gerber DJ, Hall D, Miyakawa T et al: Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci USA 2003; 100: 8993-8998.
31. Miyakawa T, Leiter LM, Gerber DJ et al: Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 2003; 100: 8987-8992.
32. Kinoshita Y, Suzuki T, Ikeda M et al: No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia. J Neural Trans 2005; 112: 1255-1262.
33. Straub RE, MacLean CJ, O'Neill FA et al: A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity. Nat Genet 1995; 11: 287-293.
34. Straub RE, Jiang Y, MacLean CJ et al: Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of mouse dysbindin, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348.
35. van den Oord E, Sullivan PF, Chen X, Kendler KS, Riley B: Identification of a high risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high density schizophrenia families. Mol Psychiatry 2003; 8: 499-510.
36. Schwab SG, Knapp M, Mondabon S et al: Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72: 185-190.
37. Tang JX, Zhou J, Fan JB et al: Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry 2003; 8: 717-718.
38. Van Den Bogaert A, Schumacher J, Schulze TG et al: The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73: 1438-1443.
39. Funke B, Finn CT, Plocik AM et al: Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004; 75: 891-898.
40. Kirov G, Ivanov D, Williams NM et al: Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiatry 2004; 55: 971-975.
41. Numakawa T, Yagasaki Y, Ishimoto T et al: Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004; 13: 2699-2708.
42. Williams NM, Preece A, Morris DW et al: Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry 2004; 61: 336-344.
43. Li T, Zhang F, Liu X et al: Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry 2005; 10: 1037-1044.
44. Weickert CS, Straub RE, McClintock BW et al: Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 2004; 61: 544-555.
45. Talbot K, Eidem WL, Tinsley CL et al: Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004; 113: 1353-1363.
46. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA: Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131-137.
47. Ikeda M, Iwata N, Suzuki T et al: Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 2004; 56: 698-700.
48. Ohtsuki T, Inada T, Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry 2004; 9: 981-983.
49. Schwab SG, Hoefgen B, Hanses C et at: Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 2005; 58: 446-450.
50. Lin MW, Curtis D, Williams N et al: Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet 1995; 5: 117-126.
51. Chumakov I, Blumenfeld M, Guerassimenko O et al: Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
52. Korostishevsky M, Kaganovich M, Cholostoy A et al: Is the G72/G30 locus associated with schizophrenia? Single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 2004; 56: 169-176.
53. Zou F, Li C, Duan S et al: A family-based study of the association between the G72/G30 genes and schizophrenia in the Chinese population. Schizophr Res 2005; 73: 257-261.
54. Korostishevsky M, Kremer I, Kaganovich M et al: Transmission disequilibrium and haplotype analyses of the G72/G30 locus: Suggestive linkage to schizophrenia in Palestinian Arabs living in the North of Israel. Am J Med Genet B Neuropsychiatr Genet 2005, [E-pub ahead of print].
55. Wang X, He G, Gu N et al: Association of G72/G30 with schizophrenia in the Chinese population. Biochem Biophys Res Commun 2004; 319: 1281-1286.
56. Addington AM, Gornick M, Sporn AL et al: Polymorphisms in the 13q33.2 gene G72/G30 are associated with childhood-onset schizophrenia and psychosis not otherwise specified. Biol Psychiatry 2004; 55: 976-980.
57. Schumacher J, Jamra RA, Freudenberg J et al: Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9: 203-207.
58. Mulle JG, Chowdari KV, Nimgaonkar V, Chakravarti A: No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families. Mol Psychiatry 2005; 10: 431-433.
59. Cao Q, Martinez M, Zhang J et al: Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997; 43: 1-8.
60. Levinson DF, Holmans P, Straub RE et al: Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000; 67: 652-663.
61. Duan J, Martinez M, Sanders AR et al: Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6823.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 2004; 75: 624-638.
62. Duan S, Du J, Xu Y et al: Failure to find association between TRAR4 and schizophrenia in the Chinese Han population. J Neural Transm 2005, [E-pub ahead of print].
63. Ikeda M, Iwata N, Suzuki T et al: No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients. Schizophr Res 2005; 78: 127-130.
64. Shaw SH, Kelly M, Smith AB et al: A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet Neuropsychiatr Genet 1998; 81: 364-376.
65. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS: Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000; 288: 678-682.
66. Levinson DF, Holmans PA, Laurent C et al: No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002; 296: 739-741.
67. Millar JK, Wilson-Annan JC, Anderson S et al: Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-1423.
68. Hennah W, Varilo T, Kestila M et al: Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 2003; 12: 3151-3159.
69. Hodgkinson CA, Goldman D, Jaeger J et al: Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 2004; 75: 862-872.
70. Thomson PA, Wray NR, Millar JK et al: Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry 2005; 10: 657-668, 616.
71. Callicott JH, Straub RE, Pezawas L et al: Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 2005; 102: 8627-8632.
72. Devon RS, Anderson S, Teague PW et al: Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder. Psychiatr Genet 2001; 11: 71-78.
73. Kockelkorn TT, Arai M, Matsumoto H et al: Association study of polymorphisms in the 5′ upstream region of human DISC1 gene with schizophrenia. Neurosci Lett 2004; 368: 41-45.
74. Zhang X, Tochigi M, Ohashi J et al: Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res 2005; 79: 175-180.
75. Sachs NA, Sawa A, Holmes SE et al: A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry 2005; 10: 758-764.
76. Miyoshi K, Honda A, Baba K et al: Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite out-growth. Mol Psychiatry 2003; 8: 685-694.
77. Ozeki Y, Tomoda T, Kleiderlein J et at: Disrupted-in-Schizophrenia-1 (DISC-1): Mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003; 100: 289-294.
78. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci 2001; 24: 479-486.
79. Chowdari KV, Mirnics K, Semwal P et al: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373-1380.
80. Chen X, Dunham C, Kendler S et al: Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am J Med Genet 2004; 129B: 23-26.
81. Cordeiro Q, Talkowski ME, Chowdari KV, Wood J, Nimgaonkar V, Vallada H: Association and linkage analysis of RGS4 polymorphisms with schizophrenia and bipolar disorder in Brazil. Genes Brain Behav 2005; 4: 45-50.
82. Sobell JL, Richard C, Wirshing DA, Heston LL: Failure to confirm association between RGS4 haplotypes and schizophrenia in Caucasians. Am J Med Genet B Neuropsychiatr Genet 2005; 139: 23-27.
83. Morris DW, Rodgers A, McGhee KA et al: Confirming RGS4 as a susceptibility gene for schizophrenia. Am J Med Genet 2004; 125B: 50-53.
84. Williams NM, Preece A, Spurlock G et al: Support for RGS4 as a susceptibility gene for schizophrenia. Biol Psychiatry 2004; 55: 192-195.
85. Lewis CM, Levinson DF, Wise LH et al: Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
86. Harrison PJ, Owen MJ: Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417-419.
87. Moghaddam B: Bringing order to the glutamate chaos in schizophrenia. Neuron 2003; 40: 881-884.
88. Morris DW, McGhee KA, Schwaiger S et al: No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 2003; 60: 167-172.
89. Hall D, Gogos JA, Karayiorgou M: The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav 2004; 3: 240-248.